CAS: 1821370-28-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | MitoPQ REF: IN-DA01ENEVCAS: 1821370-28-8 | 97% | To inquire | Tue 15 Apr 25 |
 | MitoPQ REF: 54-BUP00630CAS: 1821370-28-8 | ≥98% | 345.00 €~830.00 € | Wed 16 Apr 25 |
 | MitoPQ REF: TM-T33412CAS: 1821370-28-8 | ≥98% | 48.00 €~565.00 € | Wed 16 Apr 25 |
 | Mitopq REF: 3D-WXC37028CAS: 1821370-28-8 | Min. 95% | 331.00 €~1,923.00 € | Tue 27 May 25 |
Ref: IN-DA01ENEV
| 1g | To inquire | ||
| 5mg | 127.00 € | ||
| 10mg | 175.00 € | ||
| 25mg | 169.00 € | ||
| 50mg | 284.00 € | ||
| 100mg | 641.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 15 Apr 2025
Ref: 54-BUP00630
| 25mg | 345.00 € | ||
| 50mg | 536.00 € | ||
| 100mg | 830.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025
MitoPQ
CAS:1821370-28-8
MitoPQ (MitoParaquat) inhibits insulin-stimulated glucose uptake and plasma membrane translocation in myotubes and can be …
Formula:
C39H46I3N2P
Purity:
≥98%
Color and Shape:
Solid
Molecular weight:
954.48
Ref: TM-T33412
| 1mg | 48.00 € | ||
| 5mg | 97.00 € | ||
| 10mg | 153.00 € | ||
| 25mg | 227.00 € | ||
| 50mg | 359.00 € | ||
| 100mg | 565.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025
Mitopq
Controlled ProductCAS:1821370-28-8
Please enquire for more information about Mitopq including the price, delivery time and more detailed …
Formula:
C39H46I3N2P
Purity:
Min. 95%
Molecular weight:
954.5 g/mol
Ref: 3D-WXC37028
| 1mg | 331.00 € | ||
| 5mg | 449.00 € | ||
| 10mg | 718.00 € | ||
| 25mg | 1,202.00 € | ||
| 50mg | 1,923.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
